| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-05 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |